Site-dependent Differences in Sensitivity of LOX Human Melanoma Tumors in Nude Rats to Dacarbazine and Mitozolomide, but not to Doxorubicin and Cisplatin

Cancer Research

Volumn 52, Issue 5, 1992, Pages 1347-1351

  Kjønniksen, Inge ^a   Breistøl, Knut ^a   Fodstad, Øystein ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DACARBAZINE; DOXORUBICIN; MITOZOLOMIDE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER GRAFT; CANCER INHIBITION; CANCER RESISTANCE; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFICACY; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIFESPAN; LUNG TUMOR; MELANOMA; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR MODEL; TUMOR VOLUME;

ANIMAL; ANTINEOPLASTIC AGENTS; BONE MARROW; BONE NEOPLASMS; CISPLATIN; COMPARATIVE STUDY; DACARBAZINE; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMAN; LUNG NEOPLASMS; MELANOMA; NITROGEN MUSTARD COMPOUNDS; RATS; RATS, NUDE; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, HETEROLOGOUS;

EID: 0026560511     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Slack, N. H., and Bross, D. J. The influence of site of metastasis on tumour growth and response to chemotherapy. Br. J. Cancer, 32:78-86,1975.
2. Yap, B-S., Baker, L. H., Sinkovics, J. G., Rivkin, S. E., Bottomley, R., Thigpen, T., Burgess, M. A., Benjamin, R. S., and Bodey, G. P. Cyclophosphamide, vincristine, Adriamycin, and DTIC (CYVADIC combination chemotherapy for the treatment of advanced sarcomas. Cancer Treat. Rep., 64:93-98,1980.
3. Giuliano, A. E., Feig, S., and Eilber, F. R. Changing metastatic patterns of osteosarcoma. Cancer (Phila.), 54:2160-2164,1984.
4. Goldstein, H., McNeill, B. J., Zufall, E., Jaffe, N., and Treves, S. Changing indications for bone scintigraphy in patients with osteosarcoma. Radiology, 135:177-180,1980.
5. Goorin, A. M., Shuster, J. J., Baker, A., Horowitz, M. E., Meyer, W. H., and Link, M. P. Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study. J. Clin. Oncol., 9:600-605,1991.
6. Holst, E., Sievers, U., and Schmähl, D. Experimentelle Untersuchungen zur Chemosensibilität von Impftumoren bei unterschiedlicher Transplantationslokalisation. Z. Krebsforsch., 76:325-329, 1971.
7. Smith, K. A., Begg, A. C., and Denekamp, J. Differences in chemosensitivity between subcutaneous and pulmonary tumours. Eur. J. Cancer Clin. Oncol., 21:249-256, 1985.
8. Staroselsky, A. N., Fan, D., O'Brian, C. A., Bucana, C. D., Gupta, K. P., and Fidler, I. J. Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with Adriamycin. Cancer Res., 50: 7775-7780,1990.
9. Selby, P. J., Thomas, J. M., and Peckham, M. J. A comparison of the chemosensitivity of a primary tumour and its metastases using a human tumour xenograft. Eur. J. Cancer, 15:1425-1429,1979.
10. Phillips, R. M., Bibby, M. C., and Double, J. A. A critical appraisal of the predictive value of in vitro chemosensitivity assays. J. Natl. Cancer Inst., 82: 1457-1468,1990.
11. Kjønniksen, I., Storeng, R., Pihl, A., McLemore, T. L., and Fodstad, Ø. A human tumor lung metastasis model in athymic nude rats. Cancer Res., 49: 5148-5152,1989.
12. Kjønniksen, I., Nesland, J. M., Pihl, A., and Fodstad, Ø. Nude rat model for studying metastasis of human tumor cells to bone and bone marrow. J. Natl. Cancer Inst, 82:408-412,1990.
13. Fodstad, Ø., Aamdal, S., Pihl, A., and Boyd, M. R. Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas. Cancer Res., 45: 1778-1786,1985.
14. Aamdal, S., Fodstad, Ø., Kaalhus, O., and Pihl, A. Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors. Int. J. Cancer, 37:579-587,1986.
15. Fodstad, Ø., Aamdal, S., McMenamin, M., Nesland, J. M., and Pihl, A. A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX. Int. J. Cancer, 41:442-449,1988.
16. Fodstad, Ø., Aass, N., and Pihl, A. Assessment of tumour growth and of response to chemotherapy of human melanomas in athymic, nude mice. Br. J. Cancer, 46 (Suppl. 4); 146-149,1980.
17. Gibson, N. W., Erickson, L. C., and Hickman, J. A. Effects of the antitumor agent 8-carbamoyl-3-(2-chloro-ethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one on the DNA of mouse L1210 cells. Cancer Res., 44:1767-1771,1984.
18. Gibson, N. W., Hickman, J. A., and Erickson, L. C. DNA cross-linking and cytotoxicity in normal and transformed human cells treated in vitro with 8-carbamoyl-3-(2-chloro-ethyl)imidazo(5,1-d]-1,2,3,5-tetrazin-4(3/f)-one. Cancer Res., 44:1772-1775, 1984.
19. Stevens, M. F. G., Hickman, J. A., Langdon, S. P., Chubb, D., Vickers, L., Stone, R., Baig, G., Goddard, C., Gibson, C., Gibson, N. W., Slack, J. A., Newton, C., Lunt, E., Fizames, C., and Lavelle, F. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidaz of(5,1-d]-1,2,3,5-tetrazin-4(3/f)-one (CCRG 81045: M & B 39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res., 47:5846-5852,1987.
20. Nowak, K., Peckham, M. J., and Steel, G. G. Variation in response of xenografts of colorectal carcinomas to chemotherapy. Br. J. Cancer, 37:576-584,1978.
21. Drew, M., and Dickson, R. B. Osseous complications of malignancy. In: J. J. Lokich (ed.), Clinical Cancer Medicine: Treatment Tactics, p. 97-124. Boston: G. K. Hall, 1980.
22. Enneking, W. F. Metastatic carcinoma. In: Musculoskeletal Tumor Surgery, Vol. 2, pp. 1541-1562. New York: Churchill Livingstone, 1983.
23. Fidler, I. J., and Kripke, M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science (Washington DC), 197: 893-895, 1977.
24. Chabner, B. A., and Myers, C. E. Clinical pharmacology of cancer chemotherapy. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer. Principles & Practice of Oncology, pp. 349-395. Philadelphia: J. B. Lippincott Co., 1989.
25. Shea, T. C., Kelley, S. L., and Henner, W. D. Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines. Cancer Res., 48:527-533,1988.
26. Cantwell, B. M. J., Bozzino, J. M., Corns, P., and Harris, A. L. The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP 16-213, doxorubicin and vincristine (VPAV) for small cell lung cancer. Eur. J. Clin. Oncol., 24:123-129, 1988.
27. Scudiero, D. A., Meyer, S. A., Clatterbuck, B. E., Mattern, M. R., and Ziolkowski, C. H. Sensitivity of human cell strains having different abilities to repair O6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitosoureas. Cancer Res., 44:2467-2474,1984.
28. Fornace, A. J., Papathanasiou, M. A., Hollander, M. C., and Yarosh, D. B. Expression of the O6-methylguanine-DNA methyltransferase gene MGMT in MER and MER” human tumor cells. Cancer Res., 50:7908-7911,1990.
29. Sariban, E., Kohn, K. W., Zlotogorski, C., Laurent, G., D'Incalci, M., Day, R., III, Smith, B. H., Kornblith, P. L., and Erickson, L. C. DNA crosslinking responses of human malignant glioma cell strains to chloroethylnitrosoureas, cisplatin, and diaziquone. Cancer Res., 47:3988-3994,1987.